Cytosorbents CorporationCTSONASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank40
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-9.89M
↑ 27% vs avg
Percentile
P40
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-13.46M
Historical baseline
PeriodValueYoY Change
TTM$-9.89M+31.4%
2024$-14.43M+33.4%
2023$-21.66M+23.3%
2022$-28.23M-101.6%
2021$-14.01M-149.5%
2020$-5.61M+66.5%
2019$-16.76M-54.6%
2018$-10.84M-67.8%
2017$-6.46M+4.0%
2016$-6.73M-